According to research reviewed by Gram, vitamin D receptor activators can cause high blood calcium, a blood pattern called calcium-alkali syndrome, and kidney injury even when people take no calcium supplements. In a 2026 case series of seven elderly women, three recovered kidney function fully and one did not recover.
Gram Research analysis of a small case series in CEN Case Reports looked at seven older women who developed high blood calcium while taking vitamin D receptor activators, prescription vitamin D-like drugs used for osteoporosis and chronic kidney disease in Japan. All seven also showed a pattern called calcium-alkali syndrome-like features, meaning their blood became too alkaline and their kidneys were strained. Notably, none of the women were taking calcium supplements, which suggests the drugs alone may cause this problem. Kidney function fully recovered in three patients, partially recovered in two, and did not recover in one, and one patient died of worsening heart failure. Because the study reviewed medical records from only seven people, it cannot prove the drugs caused these changes. The authors still advise that older adults on these medications have their calcium checked regularly and be evaluated promptly for vague symptoms, kidney problems, or unusual blood test results.
Key Statistics
A 2026 case series of seven elderly women in Japan found that all of them had high blood calcium, high blood bicarbonate, and kidney injury while taking vitamin D receptor activators, and none were taking calcium supplements.
In this 2026 case series, kidney function fully recovered in three of seven patients, partially recovered in two, and did not recover in one, while one patient died of worsening heart failure.
Symptoms of high calcium appeared between 1 and 120 months after starting vitamin D receptor activators in a 2026 case series of seven patients, with a typical onset around 18 months.
In a 2026 case series of seven patients, the serum sodium-chloride difference was elevated in every patient, ranging from 36 to 53 mEq/L.
The Quick Take
- What they studied: Can prescription vitamin D-like drugs cause high blood calcium and a blood chemistry pattern called calcium-alkali syndrome, even when people do not take calcium pills?
- Who participated: Seven older women treated at one hospital in Japan who had high blood calcium while taking these drugs. Six took eldecalcitol and one took alfacalcidol. Most also had chronic kidney disease.
- Key finding: All seven women had high blood calcium, high blood bicarbonate, and kidney injury, a combination that resembles calcium-alkali syndrome. Symptoms began between 1 and 120 months after starting the drug, with a typical onset around 18 months.
- What it means for you: If you or a loved one takes a vitamin D receptor activator, regular calcium testing and prompt medical checks for unexplained symptoms or kidney changes may be worthwhile. Do not stop or change any medication without talking to your doctor first.
The Research Details
Researchers looked back at the medical records of patients at their hospital who developed high blood calcium while taking vitamin D receptor activators between April 2016 and June 2026. This type of study is called a retrospective review because it uses information that was already recorded during normal care rather than assigning patients to treatments on purpose.
To identify a calcium-alkali syndrome-like pattern, the team used a set of rules they defined in advance. Patients had to have high blood calcium, a blood bicarbonate level of 26 mmol/L or higher (a sign that the blood has become too alkaline), and acute kidney injury, which was judged using a widely used international kidney standard called KDIGO. Only patients who met all three rules were included.
Of the patients who met these rules, seven elderly women were identified. The researchers also recorded how long each woman had been taking the drug before symptoms appeared, whether she had any other source of alkali such as antacids, and a blood marker called the serum sodium-chloride difference, which can reflect alkalosis.
A case series is a useful way to notice unusual patterns that may not yet appear in larger studies. Because these drugs are widely prescribed, a rare complication can still affect many people across the population, so early descriptions like this help doctors recognize the warning signs.
The approach also has a clear limit. Since the study only looked at people who already had the problem, it cannot tell us how common the problem is or whether the drugs were the direct cause. Researchers need larger studies that also include people who took the drugs without any problems to answer those questions.
This report was published in a peer-reviewed medical journal, which means outside experts reviewed it before publication. The researchers defined their criteria in advance, which makes the case selection more transparent.
Still, the sample is very small, with only seven patients from a single hospital. The information came from routine medical records, which can be incomplete. The paper does not describe a control group, so the results cannot be compared against people taking the same drugs without this complication. Readers should treat the findings as an early warning rather than a firm estimate of risk.
What the Results Show
All seven women met the study’s rules for a calcium-alkali syndrome-like pattern. Six had been taking eldecalcitol at 0.75 micrograms per day, and one had been taking alfacalcidol at 1.0 microgram per day. None of the women were taking calcium supplements, which is notable because calcium-alkali syndrome is usually linked to heavy use of calcium pills or antacids.
The time between starting the drug and the onset of problems varied widely, from 1 to 120 months. The typical onset was around 18 months after starting treatment. This wide range suggests that the risk may not be limited to the first few months, so ongoing monitoring may matter for people who have taken these drugs for a long time.
The researchers also found that three of the seven women had no other identified source of alkali, meaning there was no clear outside reason for the blood to become too alkaline. The serum sodium-chloride difference, a blood marker linked to alkalosis, was raised in every patient, ranging from 36 to 53 mEq/L.
Kidney outcomes varied. Three women made a complete recovery, two made a partial recovery, and one did not recover. One patient died of worsening heart failure, so the study also reminds clinicians that these patients often have several serious health conditions at once.
Most of the women had chronic kidney disease before the problem began, which may make them more vulnerable because their kidneys are less able to clear extra calcium. The authors also noted that some patients had relevant concomitant medications, which are other drugs taken at the same time. The report does not name these medications in detail, but it suggests that medication reviews may be important for this group. Because the kidney injury was not always reversible, early detection appears to matter for protecting long-term kidney health.
Calcium-alkali syndrome is a well-known condition that has traditionally been linked to heavy use of calcium supplements and antacids, which can raise calcium and alkalinity together. Vitamin D receptor activators are already known to raise blood calcium and can sometimes harm the kidneys, so this report adds an important observation. The authors point out that the alkalosis part of this picture has received limited attention in these patients. This case series suggests that the calcium-alkali pattern may also appear with these drugs even without calcium pills, but larger studies are needed to confirm how often it happens.
The study looked back at medical records, which means the researchers could not control how or when patients were tested. Only seven patients were included, so the results cannot tell us how common this problem is in the general population. There was no comparison group of people taking the same drugs who did not develop the problem, which makes it harder to know whether the drugs were the direct cause.
The timing of the calcium rise and the alkalosis could not be clearly established from these records. Some patients also had other conditions and medications that could have contributed. The authors themselves stress that their main message is about monitoring and early evaluation, not about proving cause and effect. Results from one hospital in Japan may also not apply directly to people in other countries or health systems.
The Bottom Line
Based on this early report, periodic calcium testing for older adults taking vitamin D receptor activators appears to be a sensible precaution. Confidence in this recommendation is moderate, because the authors themselves recommend it as the main clinical message, even though the evidence comes from a very small case series.
Patients who notice unexplained symptoms, a drop in kidney function, or unusual blood test results should be evaluated promptly. Confidence that the drugs directly cause the calcium-alkali pattern is low to moderate, because the study cannot prove cause. Anyone with chronic kidney disease or who takes other medications that affect calcium or kidney function may need closer attention from their care team.
Older adults prescribed vitamin D receptor activators for osteoporosis or chronic kidney disease, their caregivers, and the doctors who prescribe and monitor these medications should pay the most attention to this research. People with chronic kidney disease are especially relevant to these findings.
People who do not take these medications have little need to act on this study directly. Anyone considering starting one of these drugs should discuss the possible risks, including calcium monitoring, with their doctor before beginning treatment.
Because this is a warning about a possible side effect rather than a treatment that delivers benefits, the most useful timeline is about avoiding harm. Calcium problems can develop at any point, from a few months to more than ten years after starting the drug, so monitoring is an ongoing process rather than a one-time check.
If calcium levels are checked regularly, a rise can often be spotted before serious kidney damage develops. Kidney recovery after injury varied in this study, with some people fully recovering and others not recovering at all, so early action is the most important step.
Frequently Asked Questions
Can vitamin D medications cause high calcium in older adults?
Research shows that vitamin D receptor activators can raise blood calcium in older adults. A 2026 case series of seven elderly women in Japan documented high calcium in every patient, with symptoms appearing between 1 and 120 months after starting treatment.
Can you get calcium-alkali syndrome from vitamin D drugs without taking calcium pills?
Calcium supplements are not required for this pattern to appear, according to a 2026 case series. None of the seven women were taking calcium pills, yet all developed high calcium, high blood bicarbonate, and kidney injury. The small, record-based study cannot prove the drugs were the direct cause.
Can kidney damage from vitamin D receptor activators be reversed?
Kidney recovery varied in a 2026 case series of seven patients. Three recovered fully, two recovered partially, and one did not recover. Because some kidney injury may be irreversible, researchers recommend regular calcium checks and prompt medical evaluation when symptoms or kidney test results change.
What warning signs should older adults on vitamin D receptor activators watch for?
The authors recommend prompt evaluation for nonspecific symptoms, acute kidney injury, or an elevated serum sodium-chloride difference. Vague symptoms such as tiredness or poor appetite are easy to dismiss, so anyone taking these medications should ask their doctor how often calcium and kidney tests should be done.
Want to Apply This Research?
- Log each blood calcium result, the date of each test, and the name and dose of every vitamin D-type medication. Add a weekly check-in for tiredness, appetite, thirst, nausea, or confusion, and note any kidney-related test results your doctor shares. Over time, this creates a clear record to bring to appointments.
- Bring a complete list of all medications, including over-the-counter antacids and supplements, to every appointment. Ask your doctor how often your calcium should be checked and whether your kidney function should be monitored alongside it. Avoid starting calcium pills or antacids on your own while taking these drugs.
- Set reminders for calcium and kidney tests based on your doctor’s schedule, and review your logged symptoms and results every few months. Share the summary with your care team at each visit. If you notice a sudden change in how you feel or a lab result that looks off, contact your doctor promptly rather than waiting for the next scheduled appointment.
This article summarizes a small, retrospective case series and is for general educational purposes only. It is not medical advice and does not replace guidance from your doctor or pharmacist. Do not start, stop, or change any medication, calcium supplement, or antacid based on this information. If you have symptoms such as unusual tiredness, confusion, nausea, changes in urination, or sudden swelling, contact a healthcare professional promptly.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.